A Post-marketing Database Surveillance to Investigate the Risk of Rhabdomyolysis and Myopathy in Hypercholesterolemic Patients Treated with ATOZET or Ezetimibe Atorvastatin coadministration in Japan (MK-0653C-854)

15/06/2021
23/04/2024
EU PAS number:
EUPAS41341
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

MK-0653C-854-00-v2-Final Redaction

English (1.44 MB - PDF) View document
Study results
Study results

MK-0653C-854-CSR_final redaction

English (2.68 MB - PDF) View document
Study report
Other information